Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: J Heart Lung Transplant. 2016 Aug 21;36(3):264–271. doi: 10.1016/j.healun.2016.08.016

Table 2.

Comparison of Referred by Disease Status

Cystic Fibrosis Pulmonary Fibrosis

Referred Not
Referred
P-
value
Referred Not
Referred
P-value

 n = 15  n = 8  n = 27  n = 16

Male 9 (60.0) 5 (62.5) 1.00 6 (22.2) 6 (37.5) 0.313
White 10 (71.4) 3 (37.5) 0.187 7 (25.9) 3 (18.8) 0.290
Age in years 0.337 0.130
 < 35 years 12 (80.0) 5 (62.5) 0 (0.0) 2 (12.5)
 35 – 49 1 (6.7) 3 (37.5) 10 (37.0) 4 (25.0)
 50 – 59 1 (6.7) 0 (0.0) 13 (48.2) 5 (31.25)
 > 60 years 1 (6.7) 0 (0.0) 4 (14.8) 5 (31.25)
Insurance Type 0.250 1.00
 Uninsured 3 (20.0) 0 (0.0) 1 (3.7) 0 (0.0)
 Medicare 1 (6.67) 3 (37.5) 9 (33.3) 5 (31.3)
 Medicaid 3 (20.0) 1 (12.5) 7 (25.9) 5 (31.3)
 Private Insurance 8 (53.3) 4 (50.0) 10 (37.0) 6 (37.5)
Marital Status 0.757 0.685
 Single 11 (78.6) 6 (75.0) 10 (38.5) 4 (25.0)
 Married 2 (14.3) 2 (25.0) 3 (11.5) 3 (18.8)
 Divorced/Separated/Widowed 1 (7.1) 0 (0.0) 13 (50.0) 9 (56.3)
Median Household 0.410 0.724
Income 1 (10.0) 2 (25.0) 7 (30.4) 7 (46.7)
 < $40,000 1 (10.0) 3 (37.5) 6 (26.1) 4 (26.7)
 $40,000 – $54,000 4 (40.0) 2 (25.0) 7 (30.4) 3 (20.0)
 $55,000 – $69,999 4 (40.0) 1 (12.5) 3 (13.0) 1 (6.7)
 > $70,000
Mean FEV1 of Predicted 21.2 22 0.771 45.4 50.1 0.150
(%)
Mean DLCO 30.1 35 0.136
BMI Category 0.042* 0.493
 < 17 4 (28.6) 0 (0.0) 0 (0.0) 1 (6.3)
 17 – 29.9 10 (71.4) 6 (75.0) 16 (59.3) 8 (50.0)
 ≥ 30 0 (0.0) 2 (25.0) 11 (40.7) 7 (43.8)
Relative 9 (60.0) 5 (62.5) 0.633 19 (70.4) 14 (87.5) 0.276
Contraindications
Absolute 1 (6.67) 2 (25.0) 1.00 5 (18.5) 5 (31.3) 0.460
Contraindications
Died 5 (33.3) 1 (12.5) 0.369 9 (33.3) 3 (18.8) 0.484
*

p<0.05

**

p<0.001